Junbin Wang
Impact in
- Infectious Diseases top 2%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- SARS-CoV-2 detection and testing
- Molecular Biology top 10%
- Circular RNAs in diseases
- RNA Interference and Gene Delivery
Papers in
-
- SARS-CoV-2 and COVID-19 Research 23
- COVID-19 Clinical Research Studies 2
-
- Mosquito-borne diseases and control 3
- Co-authors
- Lei Guo (1 shared paper)Huiwen Zheng (1 shared paper)George Scott Worthen (1 shared paper)Kai Feng (1 shared paper)Xiang Wang (1 shared paper)Jie Song (1 shared paper)Yun Yang (7 shared papers)Wenhai Yu (11 shared papers)
- Journals
- Signal Transduction and Targeted Therapy (7 papers)Nature Communications (2 papers)Cell (2 papers)Emerging Microbes & Infections (1 paper)Journal of Clinical Investigation (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Junbin Wang
32 papers receiving 2k citations
Junbin Wang's Hit Papers
Peers
Comparison fields: 5 of 95
- Infectious Diseases 1.2k
- Molecular Biology 560
- Immunology 146
- Neurology 84
- Biological Psychiatry 6
Countries citing papers authored by Junbin Wang
This map shows the geographic impact of Junbin Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junbin Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junbin Wang more than expected).
Fields of papers citing papers by Junbin Wang
This network shows the impact of papers produced by Junbin Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junbin Wang. The network helps show where Junbin Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Junbin Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 624 | |
| 2 | Circular RNA vaccines against SARS-CoV-2 and emerging variants Hit paper breakdown → | 2022 | 511 |
| 3 | 2020 | 198 | |
| 4 | 2022 | 113 | |
| 5 | 2021 | 105 | |
| 6 | 2020 | 102 | |
| 7 | 2020 | 90 | |
| 8 | 2017 | 57 | |
| 9 | 2022 | 55 | |
| 10 | 2023 | 40 | |
| 11 | 2022 | 39 | |
| 12 | 2019 | 23 | |
| 13 | 2022 | 17 | |
| 14 | 2020 | 16 | |
| 15 | 2023 | 14 | |
| 16 | 2020 | 12 | |
| 17 | 2024 | 11 | |
| 18 | 2022 | 10 | |
| 19 | 2024 | 10 | |
| 20 | 2024 | 6 |
About Junbin Wang
Junbin Wang is a scholar working on Infectious Diseases, Public Health, Environmental and Occupational Health, Small Animals, Epidemiology and Cancer Research, having authored 35 papers that have together received 2.1k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (23 papers), Mosquito-borne diseases and control (3 papers), COVID-19 Clinical Research Studies (2 papers), Influenza Virus Research Studies (2 papers), Gut microbiota and health (2 papers), Lung Cancer Treatments and Mutations (1 paper), Clinical Laboratory Practices and Quality Control (1 paper) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (1 paper). The work is most often cited by research in Infectious Diseases (1.2k citations), Molecular Biology (560 citations), Immunology (146 citations), Neurology (84 citations) and Biological Psychiatry (6 citations). Junbin Wang has collaborated with scholars based in China and United States. Frequent co-authors include Lei Guo, Huiwen Zheng, George Scott Worthen, Kai Feng, Xiang Wang, Jie Song, Yun Yang, Wenhai Yu, Xiaozhong Peng and Cong Tang. Their work appears in journals such as Signal Transduction and Targeted Therapy, Nature Communications, Cell, Emerging Microbes & Infections and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.